Hologic readies mid-range 4500 scanner

Like other bone densitometry vendors, Hologic is enjoying a banneryear, thanks to momentum created by Merck's Fosamax drug for thetreatment of osteoporosis. In addition to overall market growth,Hologic, of Waltham, MA, claims to have increased its market sharein the segment to around 58%, compared with about 45% a year ago.

Hologic will try to build on its success by introducing a newmid-range member of its 4500 dual-energy x-ray absorptiometryfamily of bone measurement devices, according to Wade Fox, directorof marketing. Hologic developed the new system based on feedbackfrom clinicians, Fox said.

Hologic will also show its Sahara waterless ultrasound densitometer,which is not yet available in the U.S., as well as the mini C-armproduct line the company acquired through its purchase of Fluoroscanin August, Fox said.